In pancreatic adenocarcinoma, urothelial bladder carcinoma, and cutaneous T-cell lymphoma, LAMP3+ DCs also promote immune tolerance and immunosuppression through interacting with CD8+T or tumor-infiltrating Tregs (33–35). The gene discussed is CD8A; the disease is pancreatic adenocarcinoma.